Inhibition of Lipopolysaccharide-Induced iNOS, COX-2, and TNF-α Expression by Aqueous Extract of Orixa Japonica in RAW 264.7 Cells via Suppression of NF-κB Activity

Tropical Journal of Pharmaceutical Research

Volumn 10, Issue 2, 2011, Pages 161-168

  Kang, Chang Hee ^a   Choi, Yung H ^b   Choi, Il Whan ^c   Lee, Jae Dong ^d   Kim, Gi Young ^a  

^a Jeju National University   (South Korea)

^b Dong Eui University   (South Korea)

^c Inje University College of Medicine   (South Korea)

^d Pusan National University   (South Korea)

Author keywords

Nitric oxide; Nuclear factor B; Orixa japonica; Prostaglandin E2; Tumor necrosis factor a

Indexed keywords

ACETYLCYSTEINE; ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; ORIXA JAPONICA EXTRACT; PLANT EXTRACT; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WATER;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE ACTIVITY; GENE EXPRESSION; GENE REPRESSION; MEDICINAL PLANT; NONHUMAN; ORIXA JAPONICA; PROSTAGLANDIN RELEASE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 79955943141     PISSN: 15965996     EISSN: 15969827     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Funayama S, Tanaka R, Kumekawa Y, Noshita T, Mori T, Kashiwagura T, Murata K. Rat small intestine muscle relaxation alkaloids from Orixa japonica leaves. Biol Pharm Bull 2001; 24: 100-102.
2. Noshita T, Tando M, Suzuki K, Murata K, Funayama S. New quinoline alkaloids from the leaves and stems of Orixa japonica, orijanone, isopteleflorine and 3′-O-methylorixine. Biosci Biotechnol Biochem 2001; 65: 710-713.
3. Ono H, Nishida R, Kuwahara Y. A dihydroxygamma-lactone as an oviposition stimulant for the swallowtail butterfly, Papilio bianor, from the rutaceous plant, Orixa japonica. Biosci Biotechnol Biochem 2000; 64: 1970-1973.\
4. Sharma N, Sharma VK, Seo SY. Screening of some medicinal plants for anti-lipase activity. J Ethnopharmacol 2005; 97: 453-456.
5. Kim SS, Kim JY, Lee NH, Hyun CG. Antibacterial and anti-inflammatory effects of Jeju medicinal plants against acne-inducing bacteria. J Gen
6. Good PF, Hsu A, Werner P, Perl DP, Olanow CW. Protein nitration in Parkinson's disease. J Neuropathol Exp Neurol 1998; 57: 338-342.
7. Iadecola C, Zhang F, Casey R, Nagayama M, Ross ME. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci 1997; 17: 9157-9164.
8. Amin AR, Attur M, Abramson SB. Nitric oxide synthase and cyclooxygenases: distribution, regulation, and intervention in arthritis. Curr
9. Yu HH, Wu FL, Lin SE, Shen LJ. Recombinant arginine deiminase reduces inducible nitric oxide synthase iNOS-mediated neurotoxicity in a coculture of neurons and microglia. J Neurosci Res 2008; 86: 2963-2972.
10. McCoy JM, Wicks JR, Audoly LP. The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis. J Clin Invest 2002; 110: 651-658
11. Vancheri C, Mastruzzo C, Sortino MA, Crimi N. The lung as a privileged site for the beneficial actions of PGE2. Trends Immunol 2004; 25: 40-46.
12. Hseu YC, Wu FY, Wu JJ, Chen JY, Chang WH, Lu FJ, Lai YC, Yang HL. Anti-inflammatory potential of Antrodia camphorata through inhibition of iNOS, COX-2 and cytokines via the NF-κB pathway. Int Immunopharmacol 2005; 5: 1914-1925.
13. Garlanda C, Di Liberto DD, Vecchi A, Manna MP, Buracchi C, Caccamo N, Salerno A, Dieli F, Mantovani A. Damping excessive inflammation and tissue damage in mycobacterium tuberculosis infection by toll IL-1 receptor 8/single Ig IL-1-related receptor, a negative regulator of IL-1/TLR signaling. J Immunol 2007; 179: 3119-3127.
14. Ghosh S, Karin M. Missing pieces in the NF-κB puzzle. Cell 2002; 109: 81-96.
15. Bonizzi G, Karin M. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004; 25: 280-288
16. Hayden MS, Ghosh S. Signaling to NF-κB. Gene Dev 2004; 15: 2195-224.
17. Jimi E, Ghosh S. Role of nuclear factor-kappaB in the immune system and bone. Immunol Rev 2005; 208: 80-87.
18. Baeuerle PA, Baichwal VR. NF-κB as a frequent target for immunosuppressive and antiinflammatory molecules. Adv Immunol 1997; 65: 111-137.
19. Shishodia S, Aggarwal BB. Nuclear factor-κB activation: a question of life and death. J Biochem Mol Biol 2002; 35: 28-40.
20. Vodovotz Y, Kim PK, Bagci EZ, Ermentrout GB, Chow CC, Bahar I, Billiar TR. Inflammatory modulation of hepatocyte apoptosis by nitric oxide: in vivo, in vitro, and in silico studies. Curr Mol Med 2004; 4: 753-762.
21. Moncada S, Higgs EA. Nitric oxide and the vascular endothelium. Handb Exp Pharmacol 2006; 176: 213-254.
22. Dinarello CA. Cytokines as endogenous pyrogens. J Infect Dis 1999; 179: 294-304.
23. Stuehr DJ, Marletta MA. Synthesis of nitrite and nitrate in murine macrophage cell lines. Cancer Res 1987; 47: 5590-5594.
24. Geng Y, Zhang B, Lotz M. Protein tyrosine kinase activation if required for lipopolysaccharide induction of cytokines in human blood monocytes. J Immunol 1993; 151: 6692-6700.
25. Harris SG, Padilla J, Koumas L, Ray D, Phipps RP. Prostaglandins as modulators of immunity. Trends Immunol 2002; 23: 144-150.
26. Schottelius AJ, Baldwin AS (Jr). A role for transcription factor NF-κB in intestinal inflammation. Int J Colorectal Dis 1999; 14: 601-609.
27. Baima ET, Guzova JA, Mathialagan S, Nagiec EE, Hardy MM, Song LR, Bonar SL, Weinberg RA, Selness SR, Woodard SS, Chrencik J, Hood WF, Schindler JF, Kishore N, Mbalaviele G. Novel insights into the cellular mechanisms of the anti-inflammatory effects of NF-κB essential modulator binding domain peptides. J Biol Chem 2010; 285: 13498-13506.